Alnylam Pharmaceuticals | ALNY - 现金及等价物

股票价格

311.10

每天变化

-3.70 -1.18%

每月一次

-7.46%

每年

22.70%

Q1 预测

303.95

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 40.65B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	现金及等价物	更改		日
Acadia Pharmaceuticals	USD 819.69M		27.33M	2025-12
Agios Pharmaceuticals	USD 89.13M		3.58M	2025-12
Alnylam Pharmaceuticals	USD 1.66B		167M	2025-12
Amgen	USD 9.13B		316M	2025-12
Arrowhead Research	USD 201.64M		112.94M	2025-12
BioCryst Pharmaceuticals	USD 335.91M		251.83M	2025-12
BioMarin Pharmaceutical	USD 1.31B		61.57M	2025-12
Incyte	USD 3.58B		650.78M	2025-12
Ionis Pharmaceuticals	USD 2.68B		437M	2025-12
Moderna	USD 2.6B		1.46B	2025-12
Neurocrine Biosciences	USD 713M		372.8M	2025-12
Novartis	USD 9.56B		2.9B	2025-09
PTC Therapeutics	USD 984.65M		312.03M	2025-12
Regeneron Pharmaceuticals	USD 18.87B		16.36B	2025-12
Sangamo BioSciences	USD 38.34M		13.16M	2025-06
Sanofi	EUR 7.66B		1.25B	2025-12
Sarepta Therapeutics	USD 801.28M		188.2M	2025-12
Takeda	JPY 654.94B		26.55B	2025-12
Tectonic Therapeutic	USD 253.8M		14.64M	2025-12
Ultragenyx Pharmaceutical	USD 202.51M		36.4M	2025-09
Vertex Pharmaceuticals	USD 6.61B		321.1M	2025-12
Xencor	USD 54.07M		25.78M	2025-12